In news that could be of interest to international health insurance customers, scientists have developed a way of delivering cancer treatment to targeted areas.
Professor Sylvain Martel, director of the Nanorobotics Laboratory at Polytechnique Montreal, made the breakthrough, which will allow doctors to deliver cancer drugs without harming healthy tissue in the body.
The professor came up with the method using therapeutic magnetic microcarriers, which were developed under his joint direction with Professor Jean-Christophe Leroux by Pierre Pouponneau.
Microcarriers are of use because they are able to encapsulate a dose of the therapeutic agent, which was doxorubicin in this case, as well as magnetic nanoparticles.
These magnetic nanoparticles can then be guided by an upgraded MRI system through the body's blood vessels to treat the targeted cancerous cells.
International health insurance customers could soon be benefiting from this treatment as the patent for the technology has just been issued in the US.